nasdaq value chart, page-15

no wokers chil, a few kms in the pool does me well too - i'm always a better person for it

as for simple - yes - absolutley - but i wouldn't bother any other time except for the similarities in science, and for most of a market un-schooled in the finer points of this elite area of medicine, i believe the comparison with DNDN will be 'tha thing' everyone latches onto, until better distinctions can be clearly provided to the market

for now, this is game changing work (being not a little revolutionary), so we must hold to the closet examples of success that are available to us, in order to guide our investment decisions - fortunately for everyone, Dendreon is not only successful, but their science provides us with a very close blue-print for what our mob is seeking to achieve..

.. and achieve more, with the subtle direction and paths PRR have chosen to take, which (fingers crossed) will evolve into much more than one holy grail like victories over ovarian cancer, but also many other cancers that bug we humans - claims I haven't noticed Dendreon making atm (though I must admit to not following them too closely)

anyway, onwards and upwards, and thanks for the note


good luck